Skip to main content

Compare Stocks

Date Range: 

 BioCardiaGenetic TechnologiesBrickell BiotechKiromic BioPharmaWindtree Therapeutics
SymbolNASDAQ:BCDANASDAQ:GENENASDAQ:BBINASDAQ:KRBPNASDAQ:WINT
Price Information
Current Price$3.32$3.60$0.85$5.30$1.68
52 Week RangeBuyN/ABuyN/ABuy
MarketRank™
Overall Score1.20.41.61.02.3
Analysis Score3.30.03.50.03.5
Community Score1.21.91.45.05.0
Dividend Score0.00.00.00.00.0
Ownership Score0.80.01.70.01.7
Earnings & Valuation Score0.60.01.30.01.3
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/ABuy
Consensus Price Target$9.25N/A$5.50N/A$12.25
% Upside from Price Target178.61% upsideN/A547.06% upsideN/A629.17% upside
Trade Information
Market Cap$55.75 million$54.10 million$56.89 million$38.87 million$44.11 million
Beta1.982.650.34N/A0.25
Average Volume244,8981,649,8073,023,76419,475431,441
Sales & Book Value
Annual Revenue$710,000.00$10,000.00$7.92 millionN/A$200,000.00
Price / Sales78.535,410.087.18N/A220.56
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.35 per share$0.65 per share$0.97 per shareN/A$5.48 per share
Price / Book9.495.540.88N/A0.31
Profitability
Net Income$-14,710,000.00$-4,090,000.00$-23,880,000.00N/A$-27,480,000.00
EPS($2.61)N/A($5.11)N/A($2.52)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-5,103.95%N/A-990.67%N/AN/A
Return on Equity (ROE)-496.87%N/A-187.45%N/A-43.46%
Return on Assets (ROA)-178.90%N/A-114.85%N/A-26.55%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%0.02%N/AN/A0.18%
Current Ratio1.99%10.88%3.50%N/A2.75%
Quick Ratio1.99%10.81%3.50%N/A2.75%
Ownership Information
Institutional Ownership Percentage9.01%1.39%5.93%N/A1.59%
Insider Ownership Percentage40.90%N/A10.30%N/A14.91%
Miscellaneous
Employees24N/A131931
Shares Outstanding16.79 million15.03 million66.93 million7.33 million26.26 million
Next Earnings Date5/21/2021 (Estimated)N/AN/A6/30/2021 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Windtree Therapeutics Reports Qtrly Loss Per Share Of $0.51Windtree Therapeutics Reports Qtrly Loss Per Share Of $0.51
cmlviz.com - May 13 at 12:24 PM
Analysts Advise You To Build Your Position In Windtree Therapeutics Inc. (NASDAQ:WINT)Analysts Advise You To Build Your Position In Windtree Therapeutics Inc. (NASDAQ:WINT)
stocksregister.com - May 8 at 7:09 PM
Reviewing Gene Biotherapeutics (OTCMKTS:CRXM) and Windtree Therapeutics (NASDAQ:WINT)Reviewing Gene Biotherapeutics (OTCMKTS:CRXM) and Windtree Therapeutics (NASDAQ:WINT)
americanbankingnews.com - May 6 at 1:48 PM
Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Increases By 87.1%Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Increases By 87.1%
americanbankingnews.com - April 30 at 2:18 AM
Thinking about buying stock in Trevena, Windtree Therapeutics, Ardelyx, FreightCar America, or Soligenix?Thinking about buying stock in Trevena, Windtree Therapeutics, Ardelyx, FreightCar America, or Soligenix?
morningstar.com - April 21 at 12:46 PM
Windtree Therapeutics Announces New Istaroxime Expedited Review Filing of PatentWindtree Therapeutics Announces New Istaroxime Expedited Review Filing of Patent
finance.yahoo.com - April 19 at 7:36 AM
Windtree Therapeutics, Inc. (NASDAQ:WINT) Sees Significant Drop in Short InterestWindtree Therapeutics, Inc. (NASDAQ:WINT) Sees Significant Drop in Short Interest
americanbankingnews.com - April 19 at 1:54 AM
7 Beaten Down Stocks with Significant Insider Buying7 Beaten Down Stocks with Significant Insider Buying
finance.yahoo.com - April 17 at 2:48 AM
Windtree Therapeutics Stock Gives Every Indication Of Being Significantly OvervaluedWindtree Therapeutics Stock Gives Every Indication Of Being Significantly Overvalued
finance.yahoo.com - April 12 at 11:24 PM
Have Insiders Been Buying Windtree Therapeutics, Inc. (NASDAQ:WINT) Shares This Year?Have Insiders Been Buying Windtree Therapeutics, Inc. (NASDAQ:WINT) Shares This Year?
finance.yahoo.com - March 30 at 4:14 PM
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business UpdatesWindtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
finance.yahoo.com - March 29 at 7:20 PM
Windtree Therapeutics Inc. [WINT] stock Initiated by Ladenburg Thalmann analyst, price target now $12.25Windtree Therapeutics Inc. [WINT] stock Initiated by Ladenburg Thalmann analyst, price target now $12.25
dbtnews.com - March 25 at 7:45 PM
Windtree Therapeutics Announces Closing of $30.0 Million Public OfferingWindtree Therapeutics Announces Closing of $30.0 Million Public Offering
finance.yahoo.com - March 25 at 7:45 PM
Whats Happening With SPWR Stock And WINT Stock Tuesday?What's Happening With SPWR Stock And WINT Stock Tuesday?
msn.com - March 23 at 5:38 PM
Mid-Day Market Update: Crude Oil Down 4.5%; Hoth Therapeutics Shares Spike HigherMid-Day Market Update: Crude Oil Down 4.5%; Hoth Therapeutics Shares Spike Higher
benzinga.com - March 23 at 12:38 PM
Windtree Therapeutics Announces Pricing of $30.0 Million Public OfferingWindtree Therapeutics Announces Pricing of $30.0 Million Public Offering
finance.yahoo.com - March 23 at 12:38 PM
Windtree Therapeutics Announces Proposed Public Offering of Common Stock and WarrantsWindtree Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
finance.yahoo.com - March 22 at 7:36 PM
Windtree Extends Scientific Collaboration in Heart Failure Studying Its SERCA2a Activators with the University of Milan-BicoccaWindtree Extends Scientific Collaboration in Heart Failure Studying Its SERCA2a Activators with the University of Milan-Bicocca
finance.yahoo.com - March 22 at 7:55 AM
Windtree to Present at the Oppenheimer 31st Annual Healthcare ConferenceWindtree to Present at the Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 15 at 9:10 AM
Windtree to Present at the H.C. Wainwright Global Life Sciences ConferenceWindtree to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 8 at 9:03 AM
WINT: Recent News Updates Positive For Lead Assets and ProgramsWINT: Recent News Updates Positive For Lead Assets and Programs
finance.yahoo.com - February 22 at 3:52 PM
Windtree Announces Issuance of New U.S. Patent Covering Technology on Its Redesigned AEROSURF® DeviceWindtree Announces Issuance of New U.S. Patent Covering Technology on Its Redesigned AEROSURF® Device
finance.yahoo.com - February 16 at 7:34 AM
Windtree Strengthens Its Board by Appointing Three New DirectorsWindtree Strengthens Its Board by Appointing Three New Directors
finance.yahoo.com - February 4 at 9:17 AM
Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical DevelopmentWindtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development
finance.yahoo.com - February 1 at 8:39 PM
Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19
finance.yahoo.com - January 6 at 10:32 AM
DateCompanyBrokerageAction
4/22/2021BioCardiaDawson JamesReiterated Rating
9/21/2020BioCardiaAlliance Global PartnersInitiated Coverage
8/14/2020BioCardiaMaxim GroupInitiated Coverage
11/26/2019BioCardiaBrookline Capital ManagementReiterated Rating
4/26/2021Brickell BiotechOppenheimerReiterated Rating
8/28/2020Brickell BiotechLake Street CapitalInitiated Coverage
6/26/2020Windtree TherapeuticsLADENBURG THALM/SH SHInitiated Coverage
(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.